IRIS

Perfluorohexanoic Acid (PFHxA)

CASRN 307-24-4 | DTXSID3031862

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (70 pp, 480 K) Last Updated: 04/10/2023

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Developmental 5 x 10-4
(Chronic)
Decreased postnatal (PND 0) body weight in F1 Sprague‑Dawley male and female rats BMD (HED): 4.8 x 10-2
mg/kg-day
100 Medium
Developmental 5 x 10-4
(Subchronic)
Decreased postnatal (PND 0) body weight in F1 Sprague‑Dawley male and female rats BMD (HED): 4.8 x 10-2
mg/kg-day
100 Medium


Note: BMDL 5%RD.

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (70 pp, 480 K) Last Updated: 04/10/2023
Information reviewed but value not estimated.

Note: NA

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (70 pp, 480 K) Last Updated: 04/10/2023
Information reviewed but value not estimated.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (70 pp, 480 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (70 pp, 480 K)

Not assessed under the IRIS Program.

Additional EPA toxicity information may be available by visiting the following sites:

Organ/System-Specific RfDs

System RfD (mg/kg-day) Basis POD UF Confidence
Developmental 5 x 10-4 Decreased postnatal (PND 0) body weight in F1 Sprague‑Dawley male and female rats BMD (HED): 4.8 x 10-2
mg/kg-day
100 Medium
Hepatic 4 x 10-4 Increased hepatocellular hypertrophy in adult male Crl:CD Sprague‑Dawley rats BMD (HED): 1.1 x 10-1
mg/kg-day
300 Medium
Hematologic 5 x 10-3 Decreased red blood cells in adult female Crl:CD Sprague‑Dawley rats BMD (HED): 5.2 x 10-1
mg/kg-day
100 Medium

 


You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.